Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated…
Category: Trending
Massage Heights Grows Canadian Footprint with Grand Opening in Alberta
Massage Heights, a leading massage and wellness franchise, announces further expansion into the Canadian market with…
Final Hours to Transform Your Life: Grab This Groundbreaking Best Seller ‘Heal Your Back Pain’ Now (08/18/23)
Dr. Fred’s groundbreaking book emerges as a beacon of hope for all those ensnared by the…
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has…
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), today announced the U.S. Food and…
Sanitizer Market size to grow by USD 1,129.1 million from 2022 to 2027; The increase in hygiene consciousness drives the market – Technavio
The sanitizer market size is set to grow by USD 1,129.1 million from 2022 to 2027 and register a CAGR of 4.78%,…
Northwest Medical Specialties, PLLC Introduces Revolutionary Theranostics Program for Precision Cancer Treatment, Leveraging Nuclear Medicine Technologies
Northwest Medical Specialties, a distinguished leader in cancer care, is proud to announce the launch of…
FDA Approves New Drug to Prevent RSV in Babies and Toddlers
Today, the U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial…
The Inner Circle Acknowledges, Cassandra Mitchell as a Pinnacle Lifetime Member for her contributions to the Healthcare field
Cassandra Mitchell is being recognized by Continental Who’s Who as a Pinnacle Lifetime Member for her…
Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
Intensity Therapeutics, Inc. (“Intensity” or the “Company”) (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery…